Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis

Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis

Abstract Background Radiographic progression and course of inflammation over 2 years in patients with non-radiographic axial spondyloarthritis (nr-axSpA) from the phase 3, randomized, PREVENT study are reported here. Methods In the PREVENT study, adult patients fulfilling the Assessment of SpondyloA...

Full description

Bibliographic Details
Main Authors: Juergen Braun, Ricardo Blanco, Helena Marzo-Ortega, Lianne S. Gensler, Filip Van den Bosch, Stephen Hall, Hideto Kameda, Denis Poddubnyy, Marleen van de Sande, Désirée van der Heijde, Tingting Zhuang, Anna Stefanska, Aimee Readie, Hanno B. Richards, Atul Deodhar
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Arthritis Research & Therapy
Subjects:
Axial spondyloarthritis
Non-radiographic axial spondyloarthritis
Nr-axSpA
Secukinumab
X-ray
Radiograph
Online Access:https://doi.org/10.1186/s13075-023-03051-5

Internet

https://doi.org/10.1186/s13075-023-03051-5

Similar Items